Perspective TherapeuticsCATX
13F holders, Q1 2026 (March 31)2holders
0new positions
0sold out
$4.17avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Perspective Therapeutics Inc. (CATX) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Vestor Capital, LLC ($4.6M) and Portland Investment Counsel Inc. ($1.0M).
- Company
- Perspective Therapeutics Inc.
- CUSIP
- 46489V104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 1,098,189 shares bought, net +1,098,189 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Vestor Capital, LLC | 0.33% | Add +218762.8% | 1,098,691 | $4.6M |
| Portland Investment Counsel Inc. | 0.33% | No change | 250,000 | $1.0M |
"% of holder's portfolio" is CATX's weight in each manager's 13F, not the share of Perspective Therapeutics Inc. the manager owns.